New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5412 | TC AQP1 1 | Aquaporin 1 (AQP1) channel blocker |
| 5344 | ML 349 | Selective and reversible lysophospholipase 2 (LYPLA2) inhibitor |
| 5153 | ML 240 | ATP-competitive inhibitor of p97 ATPase |
| 5422 | XL 184 | Potent VEGFR inhibitor; also inhibits other RTKs |
| 5385 | GSK 5959 | Potent and selective BRPF1 bromodomain inhibitor |
| 5353 | Gap19 | Cx43 hemichannel blocker |
| 5299 | JNJ 47965567 | Potent and selective P2X7 antagonist; brain penetrant |
| 5279 | IWP 12 | Potent Porcn inhibitor; active in vivo |
| 5243 | TC-S 7009 | High affinity and selective HIF-2α inhibitor |
| 5052 | TG 4-155 | High affinity and selective EP2 receptor antagonist |
| 4837 | AZD 3988 | Potent and selective diacylglycerol acyltransferase 1 (DGAT-1) inhibitor |
| 4624 | TC-FPR 43 | Potent FPR2 agonist |
| 4234 | 4BP-TQS | Allosteric agonist at α7 nAChR |
| 5399 | BTB1 | Selective and ATP-competitive Kif18A inhibitor |
| 5376 | Pregnenolone sulfate sodium salt | NMDA Potentiator |
| 5371 | Clemizole hydrochloride | TRPC5 blocker; also H1 antagonist |
| 5323 | WDR5 0103 | WDR5 antagonist |
| 5269 | T 5601640 | Selective LIMK2 inhibitor; antitumor |
| 5214 | IWP 4 | Potent inhibitor of Wnt/β-catenin signaling |
| 5206 | JJKK 048 | Potent and selective monoacylglycerol lipase (MAGL) inhibitor |
| 5121 | 3PO | PFKFB3 inhibitor; antiangiogenic |
| 5017 | A 85380 dihydrochloride | High affinity and selective α4β2 agonist |
| 4905 | UNC 2400 | Negative control of UNC 1999 (Cat. No. 4904) |